<DrugInformationSummary id="CDR0000816798"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Triptorelin works by first signaling the pituitary gland to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which briefly raises testosterone levels. With continued use, the pituitary gland stops making as much LH and FSH, leading to lower testosterone levels over time. This helps slow or stop the growth of cancer cells that need testosterone to grow.
It is a type of luteinizing hormone-releasing hormone (LHRH) agonist.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/triptorelin-pamoate">Triptorelin Pamoate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000468834">triptorelin pamoate</TerminologyLink><GlossaryLink ref="CDR0000045769">triptorelin pamoate</GlossaryLink><USBrandNames><USBrandName>Trelstar</USBrandName><USBrandName>Trelstar Depot</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>TRIP-toh-REH-lin PAM-oh-ayt</TermPronunciation><MediaLink ref="CDR0000707212" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000707213" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1b84d62-a369-a4b7-5c41-dd1f553a18f3&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Triptorelin Pamoate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1b84d62-a369-a4b7-5c41-dd1f553a18f3&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Triptorelin pamoate 
         is approved to treat <Strong><GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">prostate cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000478743" dictionary="Cancer.gov" audience="Patient">advanced</GlossaryTermRef>.</Para>                          
  
  <Para id="_3">Triptorelin pamoate
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Triptorelin Pamoate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/468834">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet">Hormone Therapy for Prostate Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C29523">Find Clinical Trials for Triptorelin Pamoate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2024-10-08</DateFirstPublished><DateLastModified>2025-01-08</DateLastModified></DrugInformationSummary>
